These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 8101133)

  • 1. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.
    Töröcsik A; Rakovska A; Görcs T; Vizi ES
    Brain Res; 1993 May; 612(1-2):306-12. PubMed ID: 8101133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin regulation of endogenous acetylcholine release from rat striatal slices is independent of dopaminergic tone.
    Lapchak PA; Araujo DM; Quirion R; Beaudet A
    J Neurochem; 1991 Feb; 56(2):651-7. PubMed ID: 1899109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nicotine on dopaminergic-cholinergic interaction in the striatum.
    Sandor NT; Zelles T; Kiss J; Sershen H; Torocsik A; Lajtha A; Vizi ES
    Brain Res; 1991 Dec; 567(2):313-6. PubMed ID: 1817734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological release of striatal acetylcholine (in vivo): effect of somatostatin on dopaminergic-cholinergic interaction.
    Rakovska A; Javitt D; Raichev P; Ang R; Balla A; Aspromonte J; Vizi S
    Brain Res Bull; 2003 Sep; 61(5):529-36. PubMed ID: 13679252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
    Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A
    Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the stimulatory effect of neurotensin on dopamine release in rat nucleus accumbens slices is independent of dopamine D2-receptor activation.
    Reyneke L; Russell VA; Taljaard JJ
    Brain Res; 1990 Nov; 534(1-2):188-94. PubMed ID: 1981481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]acetycholine release in rat striatal slices is not subject to dopamine heteroreceptor supersensitivity 30 months after 6-hydroxydopamine lesion of the substantia nigra.
    Löschmann PA; De Groote C; Albrecht C; Darstein M; Deransart C; Landwehrmeyer GB; Lücking CH; Feuerstein TJ
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):414-21. PubMed ID: 11330335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of acetylcholine and its dopaminergic control in slices from striatal grafts in the ibotenic acid-lesioned rat striatum.
    Wichmann T; Wictorin K; Björklund A; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):623-31. PubMed ID: 3149721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats.
    Henselmans JM; Hoogland PV; Stoof JC
    Brain Res; 1991 Dec; 566(1-2):8-12. PubMed ID: 1687666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons.
    Herman JP; Lupp A; Abrous N; Le Moal M; Hertting G; Jackisch R
    Exp Brain Res; 1988; 73(2):236-48. PubMed ID: 3145893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone enhances the release of acetylcholine from cholinergic interneurons of the striatum if the dopaminergic input is impaired.
    Sándor NT; Kiss J; Sándor A; Lendvai B; Vizi ES
    Brain Res; 1991 Jun; 552(2):343-5. PubMed ID: 1913196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin attenuates dopamine D2 agonist quinpirole-induced inhibition of midbrain dopamine neurons.
    Shi WS; Bunney BS
    Neuropharmacology; 1990 Nov; 29(11):1095-7. PubMed ID: 1982340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function.
    Fawaz CS; Martel P; Leo D; Trudeau LE
    BMC Neurosci; 2009 Aug; 10():96. PubMed ID: 19682375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.